Mouse S100a8/60B8Ag/B8Ag ORF/cDNA clone-Adeno-associate virus(AAV) plasmid (NM_013650)

Cat. No.: pGMAAV001881
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days

Pre-made Mouse S100a8/60B8Ag/B8Ag Adeno-associated virus expression plasmid (ITR-vector) for S100a8 AAV packaging, S100a8 AAV production.The purified Mouse S100a8/60B8Ag/B8Ag AAV particle serves as an invaluable asset for in-depth in vivo S100a8 studies, mechanism of action (MOA) research, and the evolution of S100a8-associated gene therapy strategies.

Our GM-AAV ITR vector is optimized with the G-NEXT™ multi-serotypes AAV vector system. Explore the G-NEXT™ system in detail.


Purchase
Shipping fee: Limited-time free
For payment issues, contact us.


Product Description

Catalog ID pGMAAV001881
Gene Name S100a8
Accession Number NM_013650
Gene ID 20201
Species Mouse
Product Type Adeno-associate virus(AAV) plasmid (overexpression)
Insert Length 270 bp
Gene Alias 60B8Ag,B8Ag,Caga,CFAg,CP-10,MRP8,p8
Fluorescent Reporter EGFP
Mammalian Cell Selection Null
Fusion Tag 3xflag (C-Terminal)
Promoter GFAP
Resistance Amplicin
ORF Nucleotide Sequence ATGCCGTCTGAACTGGAGAAGGCCTTGAGCAACCTCATTGATGTCTACCACAATTATTCCAATATACAAGGAAATCACCATGCCCTCTACAAGAATGACTTCAAGAAAATGGTCACTACTGAGTGTCCTCAGTTTGTGCAGAATATAAATATCGAAAACTTGTTCAGAGAATTGGACATCAATAGTGACAATGCAATTAACTTCGAGGAGTTCCTTGCGATGGTGATAAAAGTGGGTGTGGCATCTCACAAAGACAGCCACAAGGAGTAG
ORF Protein Sequence MPSELEKALSNLIDVYHNYSNIQGNHHALYKNDFKKMVTTECPQFVQNINIENLFRELDINSDNAINFEEFLAMVIKVGVASHKDSHKE

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    Category Cat No. Products Name
    ORF Viral Vector vGMAAV001881 Mouse S100a8 Adeno-associate virus(AAV) particle




    About GMVC

    GDU

    GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.